Hello, everyone, and how are you today? We are doing just fine, thank you, especially now that the Pharmalot campus has quieted down. The short person has departed for another day at the local summer job and the mascots are quietly snoozing in their respective corners, awaiting a steamy day. As for us, yes, we are diligently brewing cups of stimulation and foraging for interesting items. What else should we be doing? As for you, here are some items of interest to help you on your own journey. Hope all goes well and, as always, do stay in touch. We enjoy hearing from you …

Sanofi (SNY) has halted production at a plant in southern France, after an environmental group accused the drug maker of “massive air” poisoning, Reuters writes. France Nature Environment, a federation representing some 3,500 local associations, says emissions contributing to pollution at the Sanofi plant in Mourenx, which produces the epilepsy treatment valproate, had been 7,000 times above the limit allowed by French law. The organization expressed particular concern about bromopropane, a widely used solvent.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy